Nektar Therapeutics (NKTR) Short term Debt (2011 - 2020)
Nektar Therapeutics' Short term Debt was $254.14 million in Q1 2020, up 0.5% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Short term Debt (2011 - 2020) Analysis & Trends
At the end of FY2019, Short term Debt at Nektar Therapeutics came in at $252.89 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Nektar Therapeutics | 2.00 Bn | 232.24 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 254.14 Mn |
| Dec 31, 2019 | 252.89 Mn |
| Sep 30, 2015 | 125.00 Mn |
| Mar 31, 2012 | 214.96 Mn |
| Dec 31, 2011 | 214.96 Mn |
| Sep 30, 2011 | 214.96 Mn |
API Access
Nektar Therapeutics Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();